Bio-Rad Laboratories (BIO) Net Cash Flow (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Net Cash Flow for 18 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 103.25% year-over-year to $4.4 million in Q2 2026; TTM through Jun 2026 was $134.7 million, a 750.72% increase from a year earlier, with the FY2025 full-year figure at $59.3 million, down 22.18% from the prior year.
• Net Cash Flow was $4.4 million for Q2 2026 at Bio-Rad Laboratories, up from -$29.1 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $324.7 million in Q1 2022 and troughed at -$212.5 million in Q2 2022.
• A 5-year average of $2.3 million and a median of $8.2 million in 2024 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 1710.06% in 2022, down 471.44% in 2022.
• Over 5 years, Net Cash Flow stood at -$65.6 million in 2022, then grew by 27.72% to -$47.4 million in 2023, then jumped by 242.45% to $67.5 million in 2024, then soared by 98.52% to $134.0 million in 2025, then plunged by 96.72% to $4.4 million in 2026.
• The last three Net Cash Flow figures came in at $4.4 million (Q2 2026), -$29.1 million (Q1 2026), and $134.0 million (Q4 2025), per Business Quant data.